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ABSTRACT
2-Alkylsubstituted benzimidazoles (3a–h) were prepared from the acid-catalyzed reaction of 4-methyl-1,2-phenylenediamine
with corresponding carboxylic acids. Addition of these benzimidazoles to N-chloromethylbenzotriazole in the presence of
sodium amide under reflux conditions gave the novel benzimidazole-substituted benzotriazoles (5a–f). IR and 1H NMR spectros-




Benzimidazoles are of special interest because of their diverse
biological activity and clinical applications.1 This heterocyclic
system has been subjected to a large variety of structural modifi-
cations in order to synthesize derivatives with different biologi-
cal activities. It is well documented that several benzimidazoles
show chemotherapeutic2–7 and biological8–10 effects. Compounds
containing a benzotriazole moiety11–13 attached to a heterocyclic
system are of wide interest because of their diverse biologi-
cal activities. Several heterocycles containing a benzotriazole
moiety have been reported in the literature.11–17 However
benzimidazole systems containing a benzotriazole moiety are
not well represented. Preparation of the (benzimidazole)methyl-
benzotriazoles is often carried out using a three-component
reaction of benzotriazole, formaldehyde and benzimidazole.18,19
Instead, preparation of the (benzimidazole)methylbenzo-
triazoles using N-hydroxy-methylmethylbenzotriazole or
N-chloromethylbenzotriazole is more convenient and elimi-
nates the use of formaldehyde.14,20
As part of ongoing studies17,21 to explore the versatile biologi-
cal properties of benzotriazoles and benzimidazoles, we have
modified and extended these methods in order to synthesize
some novel benzimidazole-substituted benzotriazoles.
2. Experimental
All chemicals were of reagent grade quality and used without
further purification. 1-Chloromethybenzotriazole was prepared
by reaction of 1-hydroxymethyl-benzotriazole and thionyl chlo-
ride.20 Melting points were determined on an Electrothermal
digital melting point apparatus and were uncorrected. 1H NMR
spectra were recorded using Bruker 300 and 500 MHz spectrom-
eters. IR spectra were recorded using a Galaxy 500 FTIR spectro-
photometer. Microanalyses were performed on an Elemental
Vario EL III elemental analyser at the University of Arak. Reac-
tion progress was routinely monitored by thin layer chromatog-
raphy (TLC) on silica gel plates. The structures of all novel
compounds reported below were confirmed by spectro-
scopic methods and the corresponding elemental analyses are
reported below. Compounds 3a, 3b and 3d are known.22,23
2.1. General Procedure for the Preparation of Benzimidazoles
and Benzimidazole-substituted Benzotriazoles
For the preparation of substituted 5-methylbenzimidazoles
(3a–h) a mixture of 4-methyl-1,2-phenylenediamine (1.0 mmol)
and the corresponding carboxylic acid (1.0 and 0.5 mmol for
monofunctional and bifunctional acids respectively) in hydro-
chloric acid (10 mL, 4 mol L–1) was refluxed for 4 to 9 h. The
mixture was cooled and neutralized slowly with NaOH (1 mol
L–1). The precipitate was filtered to give crude benzimidazoles
(3a–h), which were then recrystallized from a mixture of etha-
nol and water (50:50). Adipic acid and succinic acid were
used as bifunctional acids for the syntheses of 3f and 3g, respec-
tively. The reaction was monitored by TLC (n-hexane/ethyl
acetate, 2:1).
For the preparation of benzimidazole-substituted benzo-
triazoles (5a–f) a mixture of sodium amide (1 mmol) and the
corresponding synthesized benzimidazole 3 (1 mmol) in dry to-
luene (5 mL) was refluxed for 4 to 6 h. Chloromethylbenzo-
triazole (1 mmol) was added to the hot suspension and refluxed
for 8 to 9 h. After cooling, crystals formed which were collected in
a funnel. The crude product was recrystallized from water. The
reaction was monitored by TLC (n-hexane/ethyl acetate, 2:1).
2.2. 2,5-Dimethyl-1H-1,3-benzimidazole (3a)
Cream crystals, yield 60%, m.p. 160–162 °C, 1H NMR
(DMSO-d6, 500 MHz), δ: 2.37 (s, 3H, CH3phenyl), 2.44 (s, 3H, CH3),
6.91–7.32 (m, 3H, phenyl), 12.01 ppm (bs, 1H, NH). IR (KBr)
ν: 3038 (N-H), 2717, 2912 (C-Haliphatic), 1030, 1224 (C-N), 858,
804 cm–1.
2.3. 2-Ethyl-5-methyl-1H-1,3-benzimidazole (3b)
Brown crystals, yield 75%, m.p. 170–172 °C, 1H NMR (DMSO
d6, 500 MHz), δ: 1.28–1.31 (t, 3H, J = 7.6 Hz, CH3ethyl), 2.76–2.81
(q, 2H, J = 7.6 Hz, CH2ethyl), 2.38 (s, 3H, CH3phenyl), 6.91–7.32 (m, 3H,
phenyl), 12.01 ppm (bs, 1H, NH). IR (KBr) ν: 3040 (N-H), 2727,
2846, 2974 (C-Haliphatic), 1041 (C-N), 808 cm
–1.
2.4. 5-Methyl-2-(trichloromethyl)-1H-1,3-benzimidazole (3c)
Brown crystals, yield 75%, m.p. 187–189 °C, 1H NMR
(DMSO-d6, 500 MHz), δ: 2.31 (s, 3H, CH3), 7.07–7.62 (m, 3H,
phenyl), 13.33 ppm (bs, 1H, NH). IR (KBr) ν: 3043 (N-H), 2957
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(C-Haliphatic), 1029, 1132, 1190 (C-N), 833, 707 cm
–1. Anal. calcd. for
C9H7N2Cl3: C, 43.32; H, 2.83; N, 11.23. Found: C, 43.51; H, 2.98; N,
10.88.
2.5. 5-Methyl-2-(2-pyridyl)-1H-1,3-benzimidazole (3d)
Grey crystals, yield 85%, m.p. 230–232 °C, 1H NMR (DMSO-d6,
500 MHz), : 2.68 (s, 3H, CH3), 6.67–8.67 (m, 7H, aromatic),
12.09 ppm (bs, 1H, NH). IR (KBr) ν: 3041 (N-H), 2950 (C-Haliphatic),
1120 (C-N), 806, 700 cm–1. Anal. calcd. for C13H11N3: C, 74.62;
H, 5.30; N, 20.08. Found: C, 74.36; H, 5.56; N, 20.32.
2.6. 5-Methyl-2-(3-pyridyl)-1H-1,3-benzimidazole (3e)
Cream crystals, yield 80%, m.p. 240–242 °C, 1H NMR
(DMSO-d6, 500 MHz), : 2.29 (s, 3H, CH3), 7.06–9.32 (m, 7H, aro-
matic), 12.99 ppm (bs, 1H, NH). IR (KBr) ν: 3047 (N-H), 2910
(C-Haliphatic), 1132, 1229 (C-N), 812, 707 cm
–1. Anal. calcd. for




Red crystals, yield 70%, m.p. 270–271 °C, 1H NMR (DMSO-d6,
500 MHz), : 1.81 (m, 4H, CH2), 2.37 (s, 6H, CH3), 2.82 (m, 4H,
CH2), 6.91–7.33 (m, 6H, phenyl), 12.00 ppm (s, 2H, NH). IR (KBr)
ν: 3038 (N-H), 2756, 2870, 2933 (C-Haliphatic), 1129 (C-N), 798 cm
–1.
Anal. calcd. for C20H22N4: C, 75.44; H, 6.96; N, 17.60. Found:
C, 75.68; H, 6.69; N, 17.68.
2.8. 5-Methyl-2-[2-(5-methyl-1H-1,3-benzimidazole-
2-yl)ethyl]-1H-1,3-benzimidazole (3g)
Pink crystals, yield 70%, m.p. 260–262 °C, 1H NMR (DMSO-d6,
500 MHz), δ: 2.38 (s, 6H, CH3), 3.06–3.07 (t, 4H, J = 4.6 Hz, CH2),
6.90–7.40 (m, 6H, phenyl), 12.18 ppm (s, 2H, NH). IR (KBr) ν: 3063
(N-H), 2792, 2980, 2924 (C-Haliphatic), 1024, 1151 (C-N), 794 cm
–1.
Anal. calcd. for C18H18N4: C, 74.45; H, 6.25; N, 19.30. Found:
C, 74.67; H, 6.11; N, 17.19.48.
2.9. 5-Methyl-2-(4-pyridyl)-1H-1,3-benzimidazole (3h)
Red crystals, yield 80%, m.p. 236–238 °C, 1H NMR (DMSO-d6,
500 MHz), : 2.44 (s, 3H, CH3), 7.06–8.75 (m, 7H, aromatic),
13.18 ppm (bs, 1H, NH). IR (KBr) ν: 3070 (N-H), 2970 (C-Haliphatic),
1004 (C-N), 804, 696 cm–1. Anal. calcd. for C13H11N3: C, 74.62;
H, 5.30; N, 20.08. Found: C, 74.34; H, 5.02; N, 20.38.
2.10. 1-[(2,5-Dimethyl)-1H-1,3-benzimidazole-
1-yl)methyl]-1H-1,2,3-benzotriazole (5a)
Cream crystals, yield 65%, m.p. 231–233 °C, 1H NMR (CDCl3,
500 MHz), : 2.50 (s, 3H, CH3phenyl), 6.83 (s, 2H, CH2),
7.13–7.67 ppm (m, 7H, aromatic). IR (KBr) ν: 3052 (C-Haromatic),
2981 (C-Haliphatic), 1675 (C=C, C=N), 1445, 740 cm
–1. Anal. calcd.




Cream crystals, yield 60%, m.p. 245 °C, 1H NMR (CDCl3,
500 MHz), : 2.17–2.19 (t, 3H, J = 4.5 Hz, CH3ethyl), 2.51–2.53 (q, 2H,
J = 5.7 Hz, CH2ethyl), 2.47 (s, 3H, CH3phenyl), 6.87 (s, 2H, CH2),
7.11–7.65 ppm (m, 7H, aromatic). IR (KBr) ν: 3049 (C-Haromatic),
2987 (C-Haliphatic), 1610, 1679 (C=C, C=N), 1440, 840, 796 cm
–1.
Anal. calcd. for C17H17N5: C, 70.08; H, 5.88; N, 24.04. Found:
C, 70.21; H, 6.05; N, 23.81.
2.12. 1-{[5-Methyl-2-(trichloromethyl)-1H-1,3-benzimidazole-
1-yl]methyl}-1H-1,2,3-benzotriazole (5c)
Cream crystals, yield 60%, m.p. 268 °C, 1H NMR (CDCl3,
500 MHz), : 2.47 (s, 3H, CH3), 7.08 (s, 2H, CH2), 7.41–8.06 ppm
(m, 7H, aromatic). IR (KBr) ν: 3019 (C-Haromatic), 2793–2910
(C-Haliphatic), 1670 (C=C, C=N), 1485, 810, 707 cm
–1. Anal. calcd. for




Grey crystals, yield 65%, m.p. 245 °C, 1H NMR (CDCl3,
300 MHz), : 2.50 (s, 3H, CH3), 7.15 (s, 2H, CH2), 7.40–8.03 ppm
(m, 11H, aromatic). IR (KBr) ν: 3030 (C-Haromatic), 2849–2974
(C-Haliphatic), 1646, 1690 (C=C, C=N), 1458, 806, 785 cm
–1. Anal.
calcd. for C20H16N6: C, 70.57; H, 4.74; N, 24.69. Found: C, 70.32;
H, 4.98; N, 24.41.
2.14. 1-{[5-Methyl-2-(3-pyridyl)-1H-1,3-benzimidazole-
1-yl]methyl}-1H-1,2,3-benzotriazole (5e)
Brown crystals, yield 65%, m.p. 255 °C, 1H NMR (DMSO-d6,
300 MHz), : 1.65 (s, 3H, CH3), 7.05 (s, 2H, CH2), 7.35, 9.33 ppm
(m, 11H, aromatic). IR (KBr) ν: 3095 (C-Haromat ic), 2995
(C-Haliphtic), 1665, 1689 (C=C, C=N), 1470, 623 cm
–1. Anal. calcd.





Red crystals, yield 60%, m.p. 280 °C, 1H NMR (DMSO-d6,
300 MHz), : 1.17–1.23 (m, 2H, CH2), 1.80–1.88 (m, 2H, CH2), 2.35
(s, 3H, CH3), 2.40 (s, 3H, CH3), 2.72–2.82 (m, 2H, CH2), 3.01–3.16
(m, 2H, CH2), 6.91 (s, 2H, CH2), 6.99–8.07 (m, 10H, aromatic),
12.05 ppm (bs, 1H, NH). IR (KBr) ν: 3150 (N-H), 2910, 2939
(C-Haliphatic), 1618, 1690 (C=C, C=N), 1454, 1409, 742 cm
–1. Anal.
calcd. for C27H27N7: C, 72.14; H, 6.05; N, 21.81. Found: C, 72.41;
H, 5.90; N, 21.63.
3. Results and Discussion
Benzimidazoles (3a–h) were prepared via an acid-catalyzed
cyclization of 4-methyl-1,2-phenylenediamine 1 with the appro-
priate carboxylic acid 2 under reflux conditions (Scheme 1). The
nucleophilic addition of benzimidazoles to 1-chloromethyl-
benzotriazole (4) in the presence of a strong base, NaNH2, under
reflux conditions afforded the novel benzimidazole-substituted
benzotriazoles (5a–f).
The 1H NMR spectra of the synthesized compounds support
the structures and the expected reactions. The 1H NMR spectra
of benzimidazoles (3a–h) exhibit the typical NH proton reso-
nance as a broad singlet at δ 12.02–13.33 ppm. The chemical shifts
of the aromatic protons appear at δ 6.67–9.32 ppm. The absorp-
tion peak for the characteristic methylene group between the
benzimidazole and the benzotriazole ring for (5a–f) appears as a
singlet in the δ 6.87–7.15 ppm region. The absence of the NH pro-
ton absorption around δ 6.67–9.32 ppm in the 1H NMR spectra
for the benzotriazoles in (5a–f) confirms the nucleophilic
addition of benzimidazoles to 1-chloromethylbenzotriazole.
However the 1H NMR spectrum of (5f) shows a NH signal at
δ 12.05 ppm, which means that one of the two NH groups of the
corresponding side chain benzimidazoles of (3f) reacts with
N-chloromethylbenzotriazole.
In conclusion, an easy procedure was developed for the prepa-
ration of bulky benzotriazoles from substituted benzimidazoles.
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The work-up procedures are very simple and the products are
easily purified through recrystallization.
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